Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07433556
PHASE1

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers

Sponsor: Il-Yang Pharm. Co., Ltd.

View on ClinicalTrials.gov

Summary

A randomized, double-blinded, partial-open, placebo/active-controlled, single/multiple dosing, dose escalation phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of IY-828026 in healthy adult volunteers

Official title: A Randomized, Double-blinded, Partial-open, Placebo/Active-controlled, Single/Multiple Dosing, Dose Escalation Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Characteristics of IY-828026 in Healthy Adult Volunteers

Key Details

Gender

All

Age Range

19 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

86

Start Date

2026-03-23

Completion Date

2027-06

Last Updated

2026-03-27

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

IY-828026

IY-828026

DRUG

Placebo

Placebo comparator

DRUG

IY-828026A

Active comparator

DRUG

IY-828026B

Active comparator

Locations (1)

Seoul National University Hospital

Seoul, South Korea